Ratings CARE Ratings Limited

Equities

CARERATING

INE752H01013

Market Closed - NSE India S.E. Other stock markets 07:43:48 2024-05-10 am EDT			5-day change	1st Jan Change
1,093 ^INR	-0.80%		-9.81%	+14.82%

May. 09	CARE Ratings Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	CI
May. 09	CARE Ratings Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI

Strengths

Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 49% by 2026.
Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
Over the last twelve months, the sales forecast has been frequently revised upwards.
Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

Weaknesses

With an expected P/E ratio at 30.1 and 24.83 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
In relation to the value of its tangible assets, the company's valuation appears relatively high.
The company is highly valued given the cash flows generated by its activity.
The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Sector: Professional Information Services

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
CARE RATINGS LIMITED	+14.82%	391M		-
MOODY'S CORPORATION	+2.51%	73.11B		B+
ICRA LIMITED	-10.75%	588M		C
KOREA RATINGS CO., LTD.	+12.04%	279M	-	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes